ALAMEDA, Calif.--(BUSINESS WIRE)--Aug. 23, 2006--Advanced Cell Technology, Inc. (OTCBB:ACTC), developers of groundbreaking human embryonic stem cell technologies to create next-generation medical therapies, will hold an investor conference call on Friday, August 25, 2006, at 12 noon Eastern, to discuss its novel technique to generate human embryonic stem cell lines from embryos while fully preserving the embryo’s potential for life and development.
